-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on RxSight, Maintains $11 Price Target

Benzinga·07/07/2026 10:06:54
Listen to the news
Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $11 price target.